scholarly journals Corneal Angiogenesis: Etiologies, Complications, and Management

10.5772/66713 ◽  
2017 ◽  
Author(s):  
Sepehr Feizi
Keyword(s):  
Corneal Angiogenesis

scholarly journals MT1-MMP Cleavage of the Antiangiogenic Proteoglycan Decorin: Role in Corneal Angiogenesis

Cornea ◽  
2011 ◽  
Vol 30 ◽  
pp. S45-S49 ◽  
Author(s):  
Tatsuya Mimura ◽  
Jin-Hong Chang ◽  
Tae-im Kim ◽  
Tatsuya Onguchi ◽  
Takashi Kojima ◽  
...  
Keyword(s):  
Corneal Angiogenesis

scholarly journals Potential Inhibitory Effect of LASSBio-596, a New Thalidomide Hybrid, on Inflammatory Corneal Angiogenesis in Rabbits

2012 ◽  
Vol 48 (4) ◽  
pp. 177-185 ◽  
Author(s):  
Joao Crispim M.L. Ribeiro ◽  
Francisco Vagnaldo Fechine ◽  
Mariana Zaira M.L. Ribeiro ◽  
Eliezer J. Barreiro ◽  
Lidia Moreira Lima ◽  
...  
Keyword(s):  
Inhibitory Effect ◽  
Corneal Angiogenesis

Corneal Angiogenesis and Lymphangiogenesis

2019 ◽  
pp. 249-262
Author(s):  
Felix Bock ◽  
Claus Cursiefen
Keyword(s):  
Corneal Angiogenesis

Relationship of Angiogenic Potential With Clinical Features in Cranial Meningiomas: A Corneal Angiogenesis Study

Neurosurgery ◽  
2010 ◽  
Vol 67 (6) ◽  
pp. 1724-1732 ◽  
Author(s):  
Zafer Orkun Toktas ◽  
Emel Akgun ◽  
Abdulkadir Ozkan ◽  
Suheyla Uyar Bozkurt ◽  
Nural Bekiroglu ◽  
...  
Keyword(s):  
Clinical Features ◽  
Angiogenic Potential ◽  
Corneal Angiogenesis ◽  
Relationship Of

Effects of topical administration of 12-methyl tetradecanoic acid (12-MTA) on the development of corneal angiogenesis

Angiogenesis ◽  
2007 ◽  
Vol 10 (1) ◽  
pp. 47-54 ◽  
Author(s):  
Nerida Cole ◽  
Emma B. H. Hume ◽  
Isabelle Jalbert ◽  
Ajay Kumar Vijay ◽  
Ravi Krishnan ◽  
...  
Keyword(s):  
Topical Administration ◽  
Tetradecanoic Acid ◽  
Corneal Angiogenesis

scholarly journals The effects of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea

2007 ◽  
Vol 79 (3) ◽  
pp. 389-394 ◽  
Author(s):  
Luiz F.M. Barros ◽  
Rubens Belfort-Jr
Keyword(s):  
Saline Solution ◽  
Male Rats ◽  
Lesion Group ◽  
Control Group ◽  
Subconjunctival Injection ◽  
Corneal Surface ◽  
Inhibition Of Angiogenesis ◽  
Corneal Angiogenesis ◽  
Computerized System ◽  
Wistar Male Rats

The purpose of this study was to evaluate the effects of the use of the subconjunctival injection of bevacizumab (Avastin®) on angiogenesis in the rat cornea. Corneas of 20 Wistar male rats were cauterized with silver nitrate crystal. Animals were divided in four groups: control group (GC) that received subconjunctivally 0.02 ml of 0.9% saline solution on the day of the lesion; group GO that received subconjunctivally 0.02 ml of bevacizumab just after the lesion; group G3 that received bevacizumab on day 3 and group G5 that received bevacizumab on day 5 after lesion. Animals were euthanized on day 7. The newly formed vessels were quantified after China Ink perfusion and photographs were obtained and analyzed in a computerized system (Image Pro-Plus®). In the control group, neovascularization covered 53.56% ± 15.11 (mean ± SD) of the corneal surface, compared with 35.57% ± 18.80 (mean ± SD) in the G0 group, 30.60%±11.82 (mean±SD) in the G3 and 35.86%±0.07 (mean±SD) in the G5. The results showed an inhibition of angiogenesis when the control group was compared with all treated groups. These results suggest that subconjunctival injection of bevacizumab is able to inhibit corneal angiogenesis independently of the day of treatment.

The Heparan Sulfate Suleparoide Inhibits Rat Corneal Angiogenesis and in vitro Neovascularization

1998 ◽  
Vol 67 (2) ◽  
pp. 133-142 ◽  
Author(s):  
UMBERTO BENELLI ◽  
GUIDO BOCCI ◽  
ROMANO DANESI ◽  
ANTONIO LEPRI ◽  
NUNZIA BERNARDINI ◽  
...  
Keyword(s):  
Heparan Sulfate ◽  
Corneal Angiogenesis
Sign in / Sign up

Export Citation Format

Share Document